StockData
Evolent Health, Inc. logo

Evolent Health, Inc. (EVH) stock

EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3065% below fair value
$3.93−0.69 (-14.94%)

Close on Nov 18, 2026Market cap $444.32MP/E –Yield –

Evolent Health free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Evolent Health's free cash flow for the twelve months ending Dec 31, 2019 was -$78.18M. For fiscal 2019 it was -$78.18M. The highest annual figure on record is $0 in fiscal 2014.

Annual free cash flow

PeriodPeriod endValueChange
FY2019Dec 31, 2019-$78.18M–
FY2018Dec 31, 2018-$60.20M–
FY2017Dec 31, 2017-$55.81M–
FY2016Dec 31, 2016-$51.04M–
FY2015Dec 31, 2015-$24.98M–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013-$24.07M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$4.03M–
Q3 FY2019Sep 30, 2019-$25.23M-287.6%
Q2 FY2019Jun 30, 2019-$21.81M–
Q1 FY2019Mar 31, 2019-$35.17M–
Q4 FY2018Dec 31, 2018-$35.40M–
Q3 FY2018Sep 30, 2018$13.45M–
Q2 FY2018Jun 30, 2018-$3.99M–
Q1 FY2018Mar 31, 2018-$34.26M–
Q4 FY2017Dec 31, 2017-$464.00K–
Q3 FY2017Sep 30, 2017-$5.10M-225.7%
Q2 FY2017Jun 30, 2017-$9.50M–
Q1 FY2017Mar 31, 2017-$40.74M–
Q4 FY2016Dec 31, 2016-$25.92M–
Q3 FY2016Sep 30, 2016$4.06M–

More Evolent Health figures

See a number that looks wrong?